Membrane Oxygenators (Membrane Oxygenator)

Devices in which blood and oxygen are separated by a semipermeable membrane, generally of Teflon or polypropylene, across which gas exchange occurs. The membrane may be arranged as a series of parallel plates or as a number of hollow fibers; in the latter arrangement, the blood may flow inside the fibers, which are surrounded by gas, or the blood may flow outside the fibers and the gas inside the fibers. (Dorland, 28th ed)

Also Known As:

Networked: 367 relevant articles (6 outcomes, 28 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1.	Philipp, Alois: 7 articles (01/2018 - 05/2002)
2.	Lehle, Karla: 6 articles (01/2018 - 11/2008)
3.	Müller, Thomas: 6 articles (01/2018 - 11/2008)
4.	Schmid, Christof: 5 articles (01/2018 - 11/2008)
5.	Wu, Chiung-Jen: 3 articles (11/2016 - 09/2010)
6.	Yip, Hon-Kan: 3 articles (11/2016 - 09/2010)
7.	Dornia, Christian: 3 articles (09/2015 - 06/2014)
8.	Lubnow, Matthias: 3 articles (11/2014 - 04/2011)
9.	Zych, Bartlomiej: 3 articles (02/2014 - 12/2011)
10.	Fukuda, Makoto: 2 articles (03/2022 - 11/2020)

Related Diseases

1.	Cardiogenic Shock 01/01/2023 - "In cardiogenic shock various short-term mechanical assistances may be employed, including an Extra Corporeal Membrane Oxygenator and other non-dischargeable devices. " 12/27/2022 - "Cardiogenic shock severity and mortality in patients receiving venoarterial extracorporeal membrane oxygenator support." 02/24/2022 - "Extracorporeal membrane oxygenator (ECMO) has been implemented in refractory postcardiotomy cardiogenic shock (PCCS) patients to maintain excellent oxygenation and hemodynamic support. " 01/01/2022 - "It is not well studied whether a secondary look by angiography (Re-Ang) after fixing the culprit lesion would be beneficial or not in cardiogenic shock (CS) supported by veno-arterial extracorporeal membrane oxygenator (VA-ECMO). " 01/01/2022 - "Could Selective Re-look Angiography Improve the Outcome of Cardiogenic Shock in Patients Under Veno-arterial Extracorporeal Membrane Oxygenator?"
2.	Hypoxia (Hypoxemia) 01/01/1994 - "The present study introduces a new experimental canine model of hepatic arterial deoxygenation using a membrane oxygenator to investigate the influence of hepatic arterial hypoxia on hepatic hemodynamics and energy metabolism. " 11/01/2021 - "The serial connection of two extracorporeal membrane oxygenators for patient with refractory hypoxemia." 09/01/2019 - "Hypoxemia on Cardiopulmonary Bypass Caused by a Patient's Oxygen Consumption Exceeding the Capacity of a Membrane Oxygenator." 11/01/2017 - "Membrane oxygenators (MOs) can be added to the circuit for concomitant, profound refractory hypoxia. " 02/01/2001 - "Regional myocardial hypoxia was induced in the left anterior descending (LAD) artery myocardium in anesthetized, open-chest dogs, using a perfusion circuit between the right atrium and the LAD artery, and a membrane oxygenator. "
3.	ST Elevation Myocardial Infarction 09/01/2010 - "Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day outcomes in patients with ST-segment elevation myocardial infarction with complicated with profound cardiogenic shock." 09/01/2010 - "Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock." 11/15/2016 - "This study investigated the 30-day and long-term prognostic outcomes in patients with ST-segment elevation myocardial infarction (STEMI) complicated with profound cardiogenic shock (CS) undergoing early routine extracorporeal membrane oxygenator (ECMO)-assisted primary percutaneous coronary intervention (PCI). " 09/01/2010 - "This study tested the hypothesis that early extracorporeal membrane oxygenator offered additional benefits in improving 30-day outcomes in patients with acute ST-segment elevation myocardial infarction complicated with profound cardiogenic shock undergoing primary percutaneous coronary intervention. " 11/01/2019 - "Impella CP and Veno-Arterial Extracorporeal Membrane Oxygenator as a sequential add-on combination circulatory support in ST-segment elevation myocardial infarction complicated by cardiogenic shock."
4.	Hypothermia 04/01/1989 - "Twenty-one patients were selected for this study, who were operated under the cardiopulmonary bypass with a standard roller pump and a membrane oxygenator under moderate hypothermia (nasopharyngeal temperature of 26-28 degrees C). " 05/01/2003 - "After a shortened history of conventional closed and open heart surgery, including hypothermia by surface cooling and extracorporeal circulation, the first application of a new membrane oxygenator developed by ML Bramson with an integrated temperature exchange system and a heart-lung machine (HLM) was reported in 1972. " 02/01/2002 - "Such an effect was evaluated for 40 patients undergoing open-heart surgery using CPB (membrane oxygenator) and systemic hypothermia. " 01/01/2000 - "All surgical procedures were performed in extracorporeal circulation (ECC) with membrane oxygenator using moderate systemic hypothermia and transseptal surgical approach to mitral valve. " 06/01/1999 - "In the setting of prolonged deep hypothermia and circulatory arrest with membrane oxygenators, normoxic cardiopulmonary bypass significantly increases histologically graded brain damage with respect to hyperoxic cardiopulmonary bypass. "
5.	Thrombocytopenia (Thrombopenia) 09/01/1997 - "Platelet adhesion on an oxygenator membrane is associated with thrombocytopenia or thrombus formation during extracorporeal circulation. " 05/01/1996 - "Bleeding during extracorporeal circulation (ECC) is often induced and/or aggravated by thrombocytopenia due to platelet-trapping in hollow fiber membrane oxygenators (HFMO). " 04/01/1999 - "Judicious management of anticoagulation, prevention of renal failure and aggressive correction of thrombocytopenia may help to lower the risk of intracranial hemorrhage in adults on extracorporeal membrane oxygenator support." 11/01/2016 - "To assess the prevalence of heparin-induced thrombocytopenia and to study platelet count trends potentially suggestive of heparin-induced thrombocytopenia in a population of extracorporeal membrane oxygenator patients. " 11/01/2016 - "Using platelet count trends to guide decision to test for heparin-induced thrombocytopenia is not an optimal strategy in extracorporeal membrane oxygenator patients. "

Related Drugs and Biologics

1.	Fibrinogen (Factor I)
2.	Vasodilator Agents (Vasodilators)
3.	Urea (Carbamide)
4.	Nitrogen
5.	Heparin (Liquaemin)
6.	Hemoglobins (Hemoglobin)
7.	Silicones
8.	Nitric Oxide (Nitrogen Monoxide)
9.	Dipyridamole (Persantine)
10.	salicylhydroxamic acid (SHAM)

Related Therapies and Procedures

1.	Percutaneous Coronary Intervention
2.	Length of Stay
3.	Cardiopulmonary Bypass (Heart-Lung Bypass)
4.	Oxygenators
5.	Extracorporeal Membrane Oxygenation